Solugen was last valued at $2B (post-money). It comes from the $50M Series D expansion of Mar 2026. The company is private, so there is no listed share price.
1 valuation. The latest, $2B post-money, was set by the Series D expansion in Mar 2026.
A private valuation is the price agreed in one transaction. The Solugen valuation of $2B is a post-money figure from the Series D expansion dated 18 Mar 2026 — the whole company measured after the $50M raised in that round was already inside it. Subtract the round and the pre-money view of the same deal is $1.9B .
The valuation holds until the next priced round or secondary sale. A private company founded in 2016 with roughly 115 people has no daily price and no order book between rounds.
The routes section explains what is realistically available for a company at this stage.
No. Solugen is a private company; its shares do not trade on a public exchange.
The last valuation is $2B (post-money, Mar 2026).
Lead investors for each round are in the funding timeline.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
